Toll Free: 1800 103 1369 Email Us:customercare@canmoney.in

Markets

Market

News Details

(22/04/2026 10:55)

Lupin Ltd launches Generic Anti-Diabetic Tablets in US

Pharma major Lupin Ltd on Wednesday announced the launch of its generic version of anti-diabetic medication dapagliflozin and metformin hydrochloride extended-release tablets in the United States, following approval from the US Food and Drug Administration.

The company stated that the tablets are available in multiple strengths: 5 mg/500 mg, 5 mg/1,000 mg, 10 mg/500 mg, and 10 mg/1,000 mg, as per its regulatory filing.

Lupin added that the launch comes after receiving approval for its abbreviated new drug application (ANDA), with the product deemed bioequivalent to Xigduo XR.
Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
CDSL – MyEasi App App Store: https://apps.apple.com/in/app/cdsl-myeasi-app/id6737304195      Google Play Store: https://play.google.com/store/apps/details?id=com.cdsl.myeasi   |   NSDL – Speede App : App Store: https://apps.apple.com/in/app/nsdl-speede-app/id922834763      Google Play Store: https://play.google.com/store/apps/details?id=com.msf.NSDL.Android